These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35935947)

  • 1. Antibodies targeting
    Singh S; Nabeela S; Barbarino A; Ibrahim AS; Uppuluri P
    Front Immunol; 2022; 13():925821. PubMed ID: 35935947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis.
    Luo G; Ibrahim AS; French SW; Edwards JE; Fu Y
    PLoS One; 2011; 6(10):e25909. PubMed ID: 22028796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.
    Uppuluri P; Singh S; Alqarihi A; Schmidt CS; Hennessey JP; Yeaman MR; Filler SG; Edwards JE; Ibrahim AS
    Front Immunol; 2018; 9():1349. PubMed ID: 29963049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
    Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
    Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.
    Singh S; Uppuluri P; Mamouei Z; Alqarihi A; Elhassan H; French S; Lockhart SR; Chiller T; Edwards JE; Ibrahim AS
    PLoS Pathog; 2019 Aug; 15(8):e1007460. PubMed ID: 31381597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
    Uppuluri P; Lin L; Alqarihi A; Luo G; Youssef EG; Alkhazraji S; Yount NY; Ibrahim BA; Bolaris MA; Edwards JE; Swidergall M; Filler SG; Yeaman MR; Ibrahim AS
    PLoS Pathog; 2018 May; 14(5):e1007056. PubMed ID: 29746596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.
    Luo G; Ibrahim AS; Spellberg B; Nobile CJ; Mitchell AP; Fu Y
    J Infect Dis; 2010 Jun; 201(11):1718-28. PubMed ID: 20415594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal IgM Antibodies Targeting
    Youssef EG; Zhang L; Alkhazraji S; Gebremariam T; Singh S; Yount NY; Yeaman MR; Uppuluri P; Ibrahim AS
    Front Immunol; 2020; 11():76. PubMed ID: 32153560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
    Xin H; Rosario-Colon JA; Eberle K
    mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.
    Huang W-C; Eberle K; Colon JR; Lovell JF; Xin H
    mSphere; 2024 Jul; 9(7):e0018924. PubMed ID: 38904363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis.
    Diez A; Arrieta-Aguirre I; Carrano G; Fernandez-de-Larrinoa I; Moragues MD
    Vaccine; 2024 Aug; 42(20):125990. PubMed ID: 38789371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice.
    Alqarihi A; Singh S; Edwards JE; Ibrahim AS; Uppuluri P
    Sci Rep; 2019 Apr; 9(1):6194. PubMed ID: 30996274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of fungal extracellular vesicles against murine candidiasis.
    Vargas G; Honorato L; Guimarães AJ; Rodrigues ML; Reis FCG; Vale AM; Ray A; Nosanchuk JD; Nimrichter L
    Cell Microbiol; 2020 Oct; 22(10):e13238. PubMed ID: 32558196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the function of Candida albicans Als3 by heterologous expression in Candida glabrata.
    Fu Y; Phan QT; Luo G; Solis NV; Liu Y; Cormack BP; Edwards JE; Ibrahim AS; Filler SG
    Infect Immun; 2013 Jul; 81(7):2528-35. PubMed ID: 23630968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
    Han Y; Rhew KY
    Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p.
    Peters BM; Ovchinnikova ES; Krom BP; Schlecht LM; Zhou H; Hoyer LL; Busscher HJ; van der Mei HC; Jabra-Rizk MA; Shirtliff ME
    Microbiology (Reading); 2012 Dec; 158(Pt 12):2975-2986. PubMed ID: 22918893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans adhesin Als3p is dispensable for virulence in the mouse model of disseminated candidiasis.
    Cleary IA; Reinhard SM; Miller CL; Murdoch C; Thornhill MH; Lazzell AL; Monteagudo C; Thomas DP; Saville SP
    Microbiology (Reading); 2011 Jun; 157(Pt 6):1806-1815. PubMed ID: 21436220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.
    Ibrahim AS; Spellberg BJ; Avenissian V; Fu Y; Filler SG; Edwards JE
    Infect Immun; 2005 Feb; 73(2):999-1005. PubMed ID: 15664943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.
    Vilanova M; Teixeira L; Caramalho I; Torrado E; Marques A; Madureira P; Ribeiro A; Ferreira P; Gama M; Demengeot J
    Immunology; 2004 Mar; 111(3):334-42. PubMed ID: 15009435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.
    Torosantucci A; Chiani P; Bromuro C; De Bernardis F; Palma AS; Liu Y; Mignogna G; Maras B; Colone M; Stringaro A; Zamboni S; Feizi T; Cassone A
    PLoS One; 2009; 4(4):e5392. PubMed ID: 19399183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.